Preoperative anatomical landmarks and longitudinal HeartMate 3 pump position in X‐rays: Relevance for adverse events
Authors:
- Gregor WidhalmGWGregor Widhalm
- Philipp AignerPAPhilipp Aigner
- Francesco MoscatoFMFrancesco Moscato
- Roxana MoayedifarRMRoxana Moayedifar
- Anne‐Kristin SchaeferASAnne‐Kristin Schaefer
- Kamen DimitrovKDKamen Dimitrov
- Daniel ZimpferDaniel Zimpfer
- Julia RiebandtJRJulia Riebandt
- Thomas SchlöglhoferThomas Schlöglhofer
Open Access
- 6 August 2024
- journal article
- research article
- Published by Wiley in Artificial Organs
- Vol. 48 (12) , 1502-1512
Abstract
Background: Left ventricular assist device (LVAD) malposition has been linked to hemocompatibility‐related adverse events (HRAEs). This study aimed to identify preoperative anatomical landmarks and postoperative pump position, associated with HRAEs during LVAD support.Methods: Pre‐ and postoperative chest X‐ray measures (≤14 days pre‐implantation, first postoperative standing, 6, 12, 18, and 24 months post‐implantation) were analyzed for their association with HRAEs over 24 months in 33 HeartMate 3 (HM3) patients (15.2% female, age 66 (9.5) years).Results: HM3 patients with any HRAE showed significantly lower preoperative distances between left ventricle and thoracic outline (dLVT) (25.3 ± 10.2 mm vs. 40.3 ± 15.5 mm, p = 0.004). A ROC‐derived cutoff dLVT ≤ 29.2 mm provided 85.7% sensitivity and 72.2% specificity predicting any HRAE during HM3 support (76.2% (>29.2 mm) vs. 16.7% (≤29.2 mm) freedom from HRAE, p < 0.001) and significant differences in cardiothoracic ratio (0.58 ± 0.04 vs. 0.62 ± 0.04, p = 0.045). Postoperative X‐rays indicated lower pump depths in patients with ischemic strokes (9.1 ± 16.2 mm vs. 38.0 ± 18.5 mm, p = 0.007), reduced freedom from any neurological event (pump depth ≤ 28.7 mm: 45.5% vs. 94.1%, p = 0.004), and a significant correlation between pump depth and inflow cannula angle (r = 0.66, p < 0.001). Longitudinal changes were observed in heart‐pump width (F(4,60) = 5.61, p < 0.001).Conclusion: Preoperative X‐ray markers are associated with postoperative HRAE occurrence. Applying this knowledge in clinical practice may enhance risk stratification, guide therapy optimization, and improve HM3 recipient management.Keywords
This publication has 49 references indexed in Scilit:
- Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart FailureJAMA, 2023
- The Society of Thoracic Surgeons Intermacs 2023 Annual Report: Focus on Magnetically Levitated DevicesThe Annals of Thoracic Surgery, 2023
- The Society of Thoracic Surgeons Intermacs 2022 Annual Report: Focus on the 2018 Heart Transplant Allocation SystemThe Annals of Thoracic Surgery, 2022
- Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized TrialJAMA, 2022
- Validation of Non-Invasive Ramp Testing for HeartMate 3ESC Heart Failure, 2020
- HeartWare Ventricular Assist Device Cannula Position and Hemocompatibility-Related Adverse EventsThe Annals of Thoracic Surgery, 2020
- Optimal Haemodynamics During Left Ventricular Assist Device Support are Associated With Reduced Haemocompatibility-Related Adverse EventsEuropean Journal of Heart Failure, 2018
- Cannula and Pump Positions Are Associated With Left Ventricular Unloading and Clinical Outcome in Patients With HeartWare Left Ventricular Assist DeviceJournal of Cardiac Failure, 2018
- Surgical Technique Influences HeartMate II Left Ventricular Assist Device ThrombosisThe Annals of Thoracic Surgery, 2013
- Diaphragmatic implantation of the HeartWare ventricular assist deviceThe Journal of Heart and Lung Transplantation, 2011